| Issue Date | Title | Author(s) |
| 2019-03 | 5PSQ - 107 aspirin and novel oral anticoagulants : reporting of adverse drug reactions | Attard, Jessica; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 1986 | Abstracts taken from projects presented by B.Pharm. / B.Ph.Tech. 1986 graduates | Serracino-Inglott, Anthony |
| 2017-05 | Academic-led experiential learning through Erasmus mobility traineeships | Wirth, Francesca; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-09 | Access to medicinal cannabis | Sciberras, Lara; Serracino-Inglott, Anthony |
| 2018-10 | Access to orphan drugs and quality of life in rare disease | Abbas, Amar; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2018-10 | Accessibility and safety of antipsychotics in the treatment of autism spectrum disorder in children and adolescents | Sadaf, Shaista; Mifsud Buhagiar, Luana; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2021 | Accreditation of an analytical method for the determination of tetrahydrocannabinol in oil | Axisa, Kersty; Vella Szijj, Janis; Tejada Rodriguez, Eva; Falzon, Pauline; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Adolescents’ use of non-prescription analgesics | Cachia, Christina; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-09 | Affordability of risperidone and aripiprazole for the treatment of autism spectrum disorder | Sadaf, Shaista; Mifsud Buhagiar, Luana; Zarb Adami, Maurice; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2020 | Amitriptyline reconsidered : the relevance of dosage regimen, serum concentrations, genotypic measures and adverse outcomes | Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2017-09 | Amitriptyline revisited : pharmacogenetic implications in antidepressant treatment | Mifsud Buhagiar, Luana; Grech, Anton; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2018-11 | Analysis of amitriptyline and its metabolites | Mifsud Buhagiar, Luana; Sammut Bartolo, Nicolette; Vella Szijj, Janis; Ferrito, Victor; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2018 | Analysis of good distribution practice inspection deficiency data of pharmaceutical wholesalers in Malta | Farrugia, Diane; Cilia, Mark; Serracino-Inglott, Anthony |
| 2020 | Analysis of patient drug usage trends in the POYC Scheme | Ruba, John Bryan; Grech, Louise; Serracino-Inglott, Anthony |
| 2018-03 | Analysis of synthesized isomeric steroids using liquid chromatography-high resolution mass spectrometry | Sammut Bartolo, Nicolette; Zoidis, Grigoris; Gikas, Evangelos; Ferrito, Victor; Serracino-Inglott, Anthony |
| 2011 | Anticoagulation services in Malta – an economic study comparing a central laboratory model vs. a point-of-care approach | Zammit, Gordon; Farrugia, Ryan; Barbara, Chris; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Grech, Victor E. |
| 2022 | Applying pharmaceutical entrepreneurship as a pharmacoeconomic paradigm shift in clinical pharmacy | Giudice, Lara; Attard-Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2018-11 | Aspirin and novel oral anticoagulants : reporting of adverse drug reactions | Attard, Jessica; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2017 | Assessing appropriateness of drug therapy in older persons : development and application of a medication assessment tool for long-term management of atrial fibrillation | Gauci, Marise; Wirth, Francesca; Camilleri, Liberato; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2017-09 | Assessing patient compliance towards monitoring needs and prescribed treatment | Vella, Jonathan; Grech, Louise; Cassar, Kathlene; Rogers, Marilyn; Balzan, Dustin; Cassar, Paul John; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2010-03 | Assessing the impact of the new ICH Q10 standard on the pharmaceutical industry | Baldacchino, Ian; Wirth, Francesca; Zammit, Marie Clare; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Zahra, Adrian |
| 2015-09 | Attitude and knowledge of parents on vaccination | Galea, Maria; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | Attitudes and beliefs of patients towards community pharmacy services | Parnis, Marie Josette; Marmarà, Vincent-Anthony; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015 | Attitudes and knowledge of parents on vaccination | Galea, Maria; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012 | Attitudes towards preconception care in Maltese women with type 1 diabetes mellitus | Sapiano, Karen; Savona-Ventura, Charles; Calleja-Agius, Jean; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023 | Auditing in a medicinal regulatory framework | Sammut, Valentina; Serracino-Inglott, Anthony |
| 2023 | Authorised medicinal products produced using recombinant DNA technology | Manicaro, Nadia; Serracino-Inglott, Anthony; Sammut Bartolo, Nicolette |
| 2018-11 | Availability of antiretroviral drugs and patient adherence : a comparison between Malta and Norway | Namulindwa, Catherine M.; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2016 | Availability of medicinal products on the Maltese market as affected by regulation | Cassar, Anna Maria; Serracino-Inglott, Anthony |
| 2015-09 | Availability of reimbursable oncology medicines in European Union member states | Cachia, Alexandra; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019-09 | Awareness and attitudes of pharmacists and physicians towards pharmacogenetic testing | Xuereb, Althea Marie; Mifsud Buhagiar, Luana; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2010-03 | Bioequivalence of doxazosin slow release tablets : a pilot study | Attard, Alison; Cilia, Mark; Zammit, Marie Clare; Wirth, Francesca; Coleiro, Bernard; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2017-09 | Biosimilars : drug substance quality issues and their impact on the safety profile of biologics | Cilia, Mark; Serracino-Inglott, Anthony; Wirth, Francesca; Borg, John-Joseph |
| 1991-03 | Blood pressure : non-invasive method to monitor drug action | Fenech, C.; Barbara, A.; Serracino-Inglott, Anthony |
| 2015-10 | Buprenorphine use compared to methadone | Pace, Maria; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Cannabidiol : knowledge and perceptions of society | Calleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2020 | Cannabis for medicinal purposes : legislative, regulatory and clinical implications | Mifsud Buhagiar, Luana; Vella, Kristina; Serracino-Inglott, Anthony; Gauci, Charmaine |
| 2023 | Cannabis for medicinal use in patients with rare diseases | Parovincaka, Jekaterina; Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Cardiovascular medicines : comparative costs and benefits | Cardona, Mark; Vella, John; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2017-09 | Challenges facing regulatory science in medical devices | Gauci, Jasmine Marie; Serracino-Inglott, Anthony; Wirth, Francesca; Azzopardi, Lilian M. |
| 2023 | Challenges in establishing a sustainable official medicines control laboratory in a small member state | Gatt Baldacchino, Elaine; Grech, Louise; Serracino-Inglott, Anthony |
| 2022 | Challenges to medical device accessibility following the New European Union regulations governing notified bodies for medical devices | Vella, Mariah; Serracino-Inglott, Anthony |
| 2022 | The changing landscape of treatment options in childhood acute lymphoblastic leukaemia | Micallef, Benjamin; Nisticò, Robert; Sarac, Sinan B.; Bjerrum, Ole W.; Butler, Dianne; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Borg, John Joseph |
| 2018-03 | Characterisation of polyphenolic and heavy metal contents in carob trees found in Malta | Galea, Luca; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Attard, Everaldo |
| 2015 | Chemical enhancement of fingerprints on various porous and non-porous surfaces | Magro, Louise; Shoemake, Claire; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-10 | Chlamydia and primary care : attitudes, practices and beliefs of health care professionals | Zammit, Anne Marie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011-10 | Chronopharmacology and the management of type I diabetes mellitus | Cole, Michelle; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011-10 | Chronopharmacology in the management of hypertension | Cassar, Deborah; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-10 | Chronopharmacology in type I diabetes | Sammut, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2010 | Chronopharmacology of antihypertensives | Attard Pizzuto, Maresca; Portelli, Jeanelle; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Azzopardi, Lilian M. |
| 2015-10 | Chronopharmacology of prednisolone in rheumatoid arthritis | Attard, Christine; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-10 | Chronopharmacology of valsartan and amlodipine | Falzon, Sephorah; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019 | Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons | Gauci, Marise; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018 | Clinical pharmacist implementation of a medication assessment tool for secondary prevention of stroke in older persons | Gauci, Marise; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | Clinical pharmacy education and practice evolvement in Malta | Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-09 | Clinical practice and pricing insights into medicine access intelligence | Cassar, Stefan; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2019-06 | Clinical skills practical sessions for undergraduate pharmacy students and as a clinical rotation for doctorate in pharmacy students | Aninon, Arianne Diane A.; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-03 | Coating of sugar spheres for the production of slow release oral dosage forms | Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017 | Collaborative effort within a multidisciplinary heart failure team | Anastasi, Alison; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014 | The combined effects of pH and acetonitrile composition on the separation of two lincosamide antibiotics | Vella Szijj, Janis; Mifsud, Martina; Sammut Bartolo, Nicolette; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2011 | Community pharmacist perception of supplementary prescribing | Wirth, Francesca; Azzopardi, Lilian M.; Gauci, Marise; Serracino-Inglott, Anthony |
| 2020 | Community pharmacists’ clinical intervention to reduce pharmaceutical waste | Cassar, Stephanie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Camilleri, Liberato |
| 2008-08 | Community pharmacists’ perception of supplementary pharmacist prescribing | Wirth, Francesca; Gauci, Marise; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2018-10 | A comparison of approved indications between regulatory agencies | Camilleri, Matthew; Borg, John-Joseph; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2022 | A comparison of European and Japanese pharmaceutical regulations : drug information and over the counter products perspective | Shimura, Shunsuke; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2011-09 | Comparison of medical devices used for blood pressure and blood glucose measurement | Mallia, Stephanie; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-06 | Comparison of patient knowledge regarding diabetes between health centre patients and the central diabetic clinic at Mater Dei Hospital | Bason, Leanne; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-09 | Comparison of post-authorisation requirements between regulatory agencies for medicinal products | Camilleri, Matthew; Borg, John-Joseph; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2013 | Compilation of a herbal medicine formulary for herbal substances in Malta and its usefulness amongst healthcare professionals | Spiteri, Maria; Attard, Everaldo; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-10 | Compliance with protocols for eye conditions | Stivala, Bianca Maria; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-10 | Compliance with protocols in dental conditions | Attard, Daniela; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2016 | Compliance with protocols in dental conditions | Attard, Daniela; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2016-03 | Concentration of ciprofloxacin in tissue of patients suffering from peripheral arterial disease | Vella, Janis; Vella, Maria; Cassar, Kevin; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2016 | Concentration of ciprofloxacin in tissue of patients suffering from peripheral arterial disease | Vella, Janis; Vella, Maria; Cassar, Kevin; Azzopardi, Lilian M; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2016 | Concept design for establishing an eco-friendly pharmaceutical production facility in Malta | Mercieca, Maria; Schembri, Frederick; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2010 | Consumer perception of the community pharmacist and community pharmacy services in Malta | Wirth, Francesca; Tabone, Francesca; Azzopardi, Lilian M.; Gauci, Marise; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2014-10 | The correlation of Accutrend® plus and Multicare-In® for the total cholesterol parameter with standard lab results | Conti, Rodianne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013 | Cost effectiveness of TNF-𝛼 inhibitors in rheumatoid arthritis | Said, Cynthia; Coleiro, Bernard; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-09 | Cost reduction related to temperature control in community pharmacies | Baron, Kristina; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015 | Could EU herbal monographs contribute to Malta’s treatment armamentarium? | Micallef, Benjamin; Attard, Everaldo; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2012-10 | Critical analysis of the dispensing process at a general hospital pharmacy | Cassar, Kathlene; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013 | Critical analysis of the dispensing process at Mater Dei Hospital | Cassar, Kathlene; Serracino-Inglott, Anthony |
| 2019-05 | Decision-maker perspectives on outcomes studied in leukaemia clinical trials : the response evaluation in leukaemia (REVALEU) study protocol | Said, Dylan; Borg, John-Joseph; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2017 | Design and application of a medication assessment tool for secondary prevention of stroke | Gauci, Marise; Wirth, Francesca; Camilleri, Liberato; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015 | Designing a national combined reporting form for adverse drug reactions and medication errors | Tanti, Amy; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2010-03 | Developing a GMP compliant training documentation system for a pharmaceutical manufacturer | Farrugia, Stephanie; Zahra, Adrian; Cassone, R.; Wirth, Francesca; Zammit, Marie Clare; Anastasi, Alison; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Azzopardi, Lilian M. |
| 2017-05 | Developing a module for undergraduate students in pharmacy practice research | Anastasi, Alison; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023 | Developing a patient centred incident reporting medical device framework | Fearne, Julian; Catania, Julia; Grech, Louise; Serracino-Inglott, Anthony |
| 2020 | Developing a questionnaire to analyse the use of medicinal cannabis for veterinary purpose | Gallo, Lovely Lynne; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2022 | Developing a risk management course for forensic professionals | Grech, Louise; Attard Pizzuto, Maresca; Gatt Baldacchino, Elaine; Serracino-Inglott, Anthony |
| 2018-09 | Developing a standard guidance for IV medications at ward level | Al-Haddad, Dania; Cutajar, Anthony; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2015-09 | Developing and auditing standard operating procedures for community pharmacy | Cassar, Michelle Marie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019-05 | Developing clinical pharmacy competences in the care of patients with cardiovascular disease | Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-03 | Developing GMP systems for partial manufacturing of pharmaceuticals | Demanuele, Aaron; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Developing modules to prepare pharmacists for prescribing | Fenech, Andrew; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-11 | Developing safe and effective medicinal products to treat Leber hereditary optic neuropathy. Clinical and regulatory challenges | Zuccarelli, Marta; Borg, John-Joseph; Serracino-Inglott, Anthony; Vella, Janis |
| 2011-06 | Developing skills for patient management in primary and secondary care scenarios | Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2023-09 | Developing strategies to improve rational use of antibiotics | Caruana, Hannah; Serracino-Inglott, Anthony; Attard Pizzuto, Maresca |
| 2017-04 | Developing tools to support patient safety in a transitional care service for methotrexate patients | Vella, Jonathan; Grech, Louise; Rogers, Marilyn; Cassar, Kathlene; Balzan, Dustin; Cassar, Paul John; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014 | Development and evaluation of a Drug Information Bulletin | Brincat, Alison; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2012-03 | Development and evaluation of a quality system as an educational tool for pharmacy students in a laboratory setting | Muscat Terribile, Corinne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013-08 | Development and evaluation of pharmacovigilance training | Axiak, Elise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-05 | Development and evaluation of research seminars for postgraduate doctorate in pharmacy students | Vella Szijj, Janis; Attard Pizzuto, Maresca; Grech, Louise; Sammut Bartolo, Nicolette; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-10 | Development and evaluation of shared paediatric pharmaceutical care plan | Fearne, Julian; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Development and evaluation of shared paediatric pharmaceutical care plans in rheumatoid arthritis | Fearne, Julian; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-05 | Development and implementation of a system to maintain contact with and assist outbound Erasmus+ students | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-03 | Development and validation of medication assessment tools specific for rheumatoid arthritis | Grech, Louise; Coleiro, Bernard; Borg, Andrew A.; Serracino-Inglott, Anthony; Ferrito, Victor; Azzopardi, Lilian M. |
| 2016 | Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management | Grech, Louise; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013 | Development in the European Union and access to medicines | Pace, Amanda; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Wismayer, Lilian; Zarb Adami, Maurice |
| 2016-04 | Development of a greener selective acylation method for steroids | Cioffi, Darren; Sammut Bartolo, Nicolette; Ferrito, Victor; Vella, Janis; Serracino-Inglott, Anthony |
| 2012-10 | Development of a herbal medicine formulary | Spiteri, Maria; Attard, Everaldo; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-10-01 | Development of a herbal medicine formulary to promote patients' safety | Spiteri, Maria; Attard, Everaldo; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-05 | Development of a new pharmaceutical analysis course | Vella, Janis; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-05 | Development of a professional doctorate in pharmacy | Azzopardi, Lilian M.; Lau, Alan H.; Serracino-Inglott, Anthony |
| 2010-08 | Development of a quality management system for clinical pharmacy services in a rehabilitation hospital | Wirth, Francesca; Gauci, Marise; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2016-04 | Development of a semi-preparative HPLC method for difluprednate | Sammut Bartolo, Nicolette; Zoidis, Grigoris; Vougogiannopoulou, N.; Ferrito, Victor; Serracino-Inglott, Anthony; Vella, J. |
| 2020 | Development of an applied course in biochemistry for pharmacy students | Vella Szijj, Janis; Attard Pizzuto, Maresca; Wirth, Francesca; Falzon, Sephorah; Mifsud Buhagiar, Luana; Gauci, Marise; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-05 | Development of an applied pharmaceutical calculations study unit | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2021 | Development of an efficient analytical method to determine tetrahydrocannabinol in cannabidiol oil | Tejada Rodríguez, Eva; Vella Szijj, Janis; Cachia, Miriana; Falzon, Pauline; Axisa, Kersty; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-05 | Development of an evaluation method for postgraduate advanced experiential sessions in a pharmacy system setting | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2003 | Development of external methods to evaluate the quality of pharmacy services offered by community pharmacists | Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Salek, Sam; Zarb Adami, Maurice |
| 1998-09 | Development of external validation tools for community pharmacy | Azzopardi, Lilian M.; Salek, Sam; Serracino-Inglott, Anthony; Zarb Adami, Maurice |
| 2009 | Development of protocols for the provision of headache and back-pain treatments in Maltese community pharmacies | Vella, Elaine; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2017-10 | Development of rheumatology shared care guidelines : improving transitional care | Grixti, Daniel Joseph; Grech, Louise; Cassar, Kathlene; Balzan, Dustin; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-03 | Development of shared care guidelines in rheumatology | Grixti, Daniel Joseph; Vella, Jonathan; Fearne, Julian; Grech, Louise; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2012 | Development of tools to assess the complication risk in maltese type 2 diabetic patients | Baldacchino, Sarah; Camilleri, Liberato; Cachia, Mario J.; Fava, Stephen; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Development, validation and evaluation of learning activities to support the reporting of adverse drug reactions during the COVID-19 pandemic | Curtolo, Elisa; Vella Szijj, Janis; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-05 | Devising laboratory practical sessions for core clinical skills | Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-10 | Dietary practices in cardiac patients | Attard Baldacchino, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-09 | Difference in anti-depressant prescribing trends between general practitioners and psychiatric specialists | Camilleri, Deborah; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2008-06 | Disease management in community pharmacy | Aquilina, Sarah; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2015-09 | Disseminating information to the public on women’s health | Warrington, Nicola; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-10 | Dissemination of protocols for the management of gastro-intestinal disorders | Carbonaro, Marija Carmen; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2009-11 | Distribution of gentamicin in ischaemic peripheries | Zammit, Marie Clare; Azzopardi, Lilian M.; LaFerla, Godfrey; Cassar, Kevin; Serracino-Inglott, Anthony; Zarb Adami, Maurice |
| 2016-05 | Doctorate of pharmacy students’ evaluation of drug information and statistics tutorial | Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Documenting and assessing the pharmaceutical care service within a rheumatology department : a 5 year overview | Grech, Louise; Borg, Andrew A.; Coleiro, Bernard; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Drug administration systems in geriatric institutions | Cassar, Angela; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Drug interactions and bleeding complications with rivaroxaban compared to warfarin | Cardona, Mark; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 1991-03 | Drugs and the elderly - can compliance be improved? | Serracino-Inglott, Anthony |
| 2014-10 | An economic and feasibility testing for point-of-care testing for total cholesterol using Accutrend® Plus and Multicare-In® | Conti, Rodianne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2016-10 | Economic implications of human papillomavirus vaccination in Malta | von Brockdorff, Bettina; Sammut Bartolo, Nicolette; von Brockdorff, Philip; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-09 | The economics of medicine use in in vitro fertilisation | Abela, Christina Noella; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012 | Editorial | Serracino-Inglott, Anthony |
| 2014 | Editorial | Serracino-Inglott, Anthony |
| 2013 | Editorial | Serracino-Inglott, Anthony |
| 2011 | Editorial : evolvement of ward and clinical pharmacy | Serracino-Inglott, Anthony |
| 2015 | Editorial : Scholarship for advanced studies in pharmacy | Serracino-Inglott, Anthony |
| 2016 | Editorial : the journey to excellence in research for doctorate in pharmacy candidates | Serracino-Inglott, Anthony |
| 1996-01 | Editorial [Journal of Euromed Pharmacy, 1(3)] | Serracino-Inglott, Anthony |
| 2020 | Education and training in veterinary pharmaceutical sciences | Butler, Dianne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2010-03 | The effect of temperature changes on the quality of pharmaceutical products during international transportation | Farrugia, H.; Brincat, R.; Zammit, Marie Clare; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Zarb Adami, Maurice |
| 2016-10 | Effect of treating sleep apnoea on other co-morbidities | Cassar, Yanica; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Vella, Janis; Montefort, Stephen; Deguara, Christopher |
| 2021 | Effects of ph and amount of acetonitrile on the separation of cannabinoids | Tejada, Eva; Vella Szijj, Janis; Cachia, Miriana; Falzon, Pauline; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2009-11 | The effects of treatment on the quality of life in rheumatoid arthritis | Falzon, S.; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Anastasi, Alison; Azzopardi, Lilian M.; Borg, Andrew A.; Coleiro, Bernard; Cassar, Paul John; Camilleri, Florinda; Cassar, K.; Mallia, Carmel |
| 2023 | An efficient HPLC-UV method for determination of tetrahydrocannabinol in oil | Tejada Rodriguez, Eva; Vella Szijj, Janis; Cachia, Miriana; Falzon, Pauline; Axisa, Kersty; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-09 | Emerging patterns in the clinical development of medicines in paediatric oncology | Micallef, Benjamin; Borg, John-Joseph; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2019-09 | Emerging treatments for Leber hereditary optic neuropathy and retinitis pigmentosa | Zuccarelli, Marta; Borg, John-Joseph; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2021 | Emerging treatments for Retinitis Pigmentosa | Zuccarelli, Marta; Borg, John-Joseph; Vella Szijj, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2010 | An English-Maltese dictionary of medical and pharmaceutical terms | Spiteri, Miran; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Azzopardi, Lilian M. |
| 2017-05 | Enhancing data retrieval and analysis skills among doctorate in pharmacy students | Attard Pizzuto, Maresca; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019-05 | Enhancing patient safety through interactive education | Attard, Annalise; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2022 | Entrepreneurship in pharmaceutical processes | Giudice, Lara; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2020 | Establishment of direct patient-pharmacist intervention within an interdisciplinary team in paediatric oncology | Falzon, Sephorah; Grech, Louise; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015 | European Union pharmacovigilance capabilities : potential for the new legislation | Borg, John-Joseph; Tanti, Amy; Kouvelas, Dimitrios; Lungu, Calin; Pirozynski, Michal; Serracino-Inglott, Anthony; Aislaitner, George |
| 2015-09 | Evaluating requests for advice from community pharmacists | Warrington, Lisa; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-09 | Evaluating shared care practice in pharmacy | Said, Analise; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013-08 | Evaluation of a formulary for non-British National Formulary cited items | Corso, Daniel; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019-05 | Evaluation of a pharmacy students research symposium | Vella Szijj, Janis; Wirth, Francesca; Sammut Bartolo, Nicolette; Attard Pizzuto, Maresca; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013 | Evaluation of a quality system developed for pharmacy teaching laboratories | Muscat Terribile, Corinne; Wirth, Francesca; Zammit, Marie Clare; Vella Szijj, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-09 | Evaluation of an innovative teaching method : buzz sessions | Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Wirth, Francesca; Vella Szijj, Janis; Borg, Kurt A.; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Evaluation of educational seminar on the analysis of pesticides in cannabis | Vella Szijj, Janis; Ronsisvalle, Simone; Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-05 | Evaluation of new pharmaceutical compounding practicals | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-05 | Evaluation of practical sessions for the pharmaceutical technology course | Vella, Janis; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-06 | Evaluation of prophylactic practice for venous thromboembolism | Grech, Jeanine; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013-08 | Evaluation of the clinical pharmacy services at a rehabilitation hospital | Agius, Jonathan; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013 | Evaluation of the impact of a pharmaceutical care service offered to rheumatoid arthritis patients within an ambulatory setting | Grech, Louise; Coleiro, Bernard; Borg, Andrew A.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-10 | Evaluation of the pharmacy practice resource unit | Azzopardi, Jaclyn; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019-05 | Evaluation of using case studies to mobilise knowledge about toxicology | Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Evaluation of virtual pharmacy students' research symposium | Vella Szijj, Janis; Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Wirth, Francesca; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-09 | Evidence-based standards for clinical pharmacy practice | Attard, Jessica; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2017-09 | Evolvement of European Union regulations on innovative medicines | Agius, Roberta; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2017-05 | Experiential clinical rotations for students following a doctorate in pharmacy course | Grech, Louise; Cassar, Kathlene; Agius, Ruth; Cutajar, Anthony; Falzon, Stephen; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023 | An exploratory study of the impact of COVID-19 vaccine spontaneous reporting on masking signal detection in EudraVigilance | Micallef, Benjamin; Dogné, Jean-Michel; Sultana, Janet; Straus, Sabine M. J. M.; Nisticò, Robert; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2019 | Exploring views of pharmacists on antibacterial prescribing : a Maltese perspective | Attard Pizzuto, Maresca; Camilleri, Liberato; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015 | Extemporaneous preparations from the past | Camilleri, Angelique; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019-09 | Extractability of polyphenols from local herbs using traditional extemporaneous preparations | Rapa, Nicholas; Attard, Everaldo; Serracino-Inglott, Anthony |
| 2016 | Factors affecting penetration of ciprofloxacin in lower extremity ischemic tissues | Vella Szijj, Janis; Vella, Maria; Cassar, Kevin; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2014-10 | Factors influencing haemoglobin levels in chronic medicine users | Joslin, Rebecca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | Factors influencing reporting of medical device related incidents in the Maltese healthcare system | Cardona Xuereb, Paula; Serracino-Inglott, Anthony |
| 2012-09 | Faecal occult blood testing in community pharmacy | Agius, Adrian M.; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | Falsified medicines directive : challenges faced by small member states | Almojero, Danielle Claire E.; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2014-03 | Feasibility of a laboratory setup for bioavailability and bioequivalence studies | Farrugia, Nathaniel; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2010-03 | Feasibility of production of intravenous fluids in Malta | Vella, T.; Zammit, Marie Clare; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Zarb Adami, Maurice |
| 2016-04 | Feasibility of solvent waste management | Tabone, Shirley; Vella, Janis; Sammut Bartolo, Nicolette; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019-03 | Focusing audits on patient safety | Attard, Annalise; Wirth, Francesca; Muscat, Caroline; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-10 | A framework for a register of biological agents in rheumatology | Camilleri, Florinda; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Gastric acid control, amylase activity and proton pump inhibitors | Galea, Charlene; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2015-09 | A glossary of risk management terminology for use in a pharmaceutical setting | Manfre, Matthew; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2016-04 | Good distribution practice guidelines | Giudice, Luca; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Good distribution practice training for medical device industry | Grech, Louise; Fearne, Julian; Farrugia, Karen; Gatt Baldacchino, Elaine; Serracino-Inglott, Anthony |
| 2013 | Guideline comparison and assessment of prescribing trends in Parkinson's disease | Abdul-Aziz, Asmaa; Gauci, Marise; Azzopardi, Lilian M.; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2013 | Health-related quality of life and hormone replacement therapy | Captur, Clarissa; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-09 | Homogenisation techniques for method development for the analysis of ciprofloxacin in tissue | Vella, Janis; Vella, Maria; Sammut Bartolo, Nicolette; Sammut, Carmel; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2021 | How to think like Francke for a global vision in challenging times | Serracino-Inglott, Anthony |
| 2023 | HPLC-UV method development and validation to monitor difluprednate synthesis | Sammut Bartolo, Nicolette; Vella Szijj, Janis; Ferrito, Victor; Serracino-Inglott, Anthony |
| 2012-10 | Human papillomavirus awareness | Brincat, Angie Marie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-03 | Identification of pharmaceutical care needs for rheumatoid arthritis patients on methotrexate | Grech, Louise; Coleiro, Bernard; Borg, Andrew A.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Identifying patient-centred training needs for pharmaceutical good distribution practice | Bacayo, May Florence D.; Grech, Louise; Serracino-Inglott, Anthony |
| 2012-10 | Impact of a pharmacist driven breast cancer awareness intervention | Fenech, Daniela; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013-08 | Impact of chronic renal failure on bone status | Ghio, Daniela; Farrugia, Emanuel; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-11 | Impact of cultural variations on autism spectrum disorder treatment | Sadaf, Shaista; Attard Pizzuto, Maresca; Mifsud Buhagiar, Luana; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2018-09 | The impact of rare diseases on health related quality of life | Abbas, Amar; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2017-10 | Impact of rivaroxaban in cardiovascular disease | Cardona, Mark; Wirth, Francesca; Serracino-Inglott, Anthony; Xuereb, Robert G.; Azzopardi, Lilian M. |
| 2018-09 | The impact of the medicinal products identifier on wholesale distribution | Miceli, Cristina; Serracino-Inglott, Anthony |
| 2013 | Impacting cardiovascular disease risk management | Aquilina, Sarah; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2022 | Implementation of a framework for the MMA Academy for patient-centred excellence and innovation in regulatory sciences | Falzon, Sephorah; Mamo, Maria; Mifsud, Buhagiar; Serracino-Inglott, Anthony |
| 2013-08 | Implementation of quality of life tools in English and Maltese | Vella, Caroline Maria; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2009-11 | Implementation of the pharmacy of your choice scheme and interprofessional relations | Mahoney, R.; Wirth, Francesca; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2018 | Implications of mobile phase composition and pH on the chromatographic separation of amitriptyline and its metabolite nortriptyline | Mifsud Buhagiar, Luana; Scorpiniti, Manuel; Sammut Bartolo, Nicolette; Vella Szijj, Janis; Ferrito, Victor; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 1985-08 | The importance of biochemical pharmacology in the interpretation of forensic toxicological analysis | Serracino-Inglott, Anthony; Zarb Adami, Maurice; Camilleri Novak, D. |
| 2013-08 | Improvement in yield in the production of slow release oral dosage forms | Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-10 | Improving patient monitoring of methotrexate across transitional care settings | Vella, Jonathan; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-09 | Improving sample preparation for the analysis of ciprofloxacin in human plasma | Vella, Janis; Busuttil, Francesca; Sammut Bartolo, Nicolette; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2022 | Improving the data quality of spontaneous ADR reports : a practical example from Malta | Zuccarelli, Marta; Micallef, Benjamin; Butler, Dianne; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2015-09 | Improving the yield in orthoesterification of steroids | Sammut Bartolo, Nicolette; Mallia, Christopher D.; Vella, Janis; Serracino-Inglott, Anthony; Ferrito, Victor |
| 2023 | Inappropriate prescribing in community pharmacy practice | Salomone, Philippa Galea; Serracino-Inglott, Anthony; Attard Pizzuto, Maresca |
| 2017-09 | Incorporation of green principles in pharmacy education | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-05 | Increasing student participation and theory application in pharmaceutical technology lectures | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2010-03 | Increasing the yield in the production of slow release pellets in the manufacture of solid oral dosage forms | Bartolo, Nicolette; Mifsud, L. M.; Anastasi, L.; Azzopardi, Lilian M.; Zammit, Marie Clare; Wirth, Francesca; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2016-05 | Industrial pharmacy visits for pharmaceutical technology students | Sammut Bartolo, Nicolette; Attard Pizzuto, Maresca; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Influenza and COVID-19 vaccine hesitancy in pharmacists and pharmacy students | Sammut Bartolo, Nicolette; Grech, Victor E.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 1999-09 | An innovative auditing system : validation of community pharmacy | Azzopardi, Lilian M.; Salek, Sam; Serracino-Inglott, Anthony; Zarb Adami, Maurice |
| 2020 | Innovative regulatory framework in community pharmacy | Lamgaro, Marina; Serracino-Inglott, Anthony |
| 2017 | An innovative treatment adherence tool | Anastasi, Alison; Grech, Louise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Integrated collaborative care models | Anastasi, Alison; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | An inter-professional approach towards understanding the science, myths and realities of COVID-19 pandemic | Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-10 | An interactive approach to the newsletter for the department of pharmacy | Sammut, Marion; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2001 | Interferon gamma induction in human melanoma cell/allogeneic leukocyte co-cultures is enhanced by interleukin 18 but drug resistant melanoma cells are poorer inducers of IFN-gamma | Micallef, Mark J.; Darmanin, Stephanie; Buhagiar, Joseph A.; Camilleri-Podesta, Marie Therese; Yamauchi, Hiroshi; Kurimoto, Masashi; Serracino-Inglott, Anthony; Ellul-Micallef, Roger |
| 2021 | The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites | Mifsud Buhagiar, Luana; Casha, Marilyn; Grech, Anton; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2017-05 | Introducing journal club sessions for doctorate in pharmacy students | Attard Pizzuto, Maresca; Grech, Louise; Sammut Bartolo, Nicolette; Vella, Janis; Wirth, Francesca; Pham, Jennifer T.; Haaf-Mactal, Christina; Lau, Alan H.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | Introducing the risk concept in pharmaceutical studies : from art to science | Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013 | Investigating the anti-oestrogenic effect of p-Synephrine and de novo design of oestrogen receptor modulating molecules | Pace Bardon, C.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2022 | ISO 17025:2017 : standard for forensic professionals : a course development | Rivera, Rogelio; Grech, Louise; Serracino-Inglott, Anthony |
| 2011 | Journal of Euromed pharmacy : issue 1 | Serracino-Inglott, Anthony |
| 2012 | Journal of Euromed pharmacy : issue 2 | Serracino-Inglott, Anthony |
| 2013 | Journal of Euromed pharmacy : issue 3 | Serracino-Inglott, Anthony |
| 2014 | Journal of Euromed pharmacy : issue 4 | Serracino-Inglott, Anthony |
| 2015 | Journal of Euromed pharmacy : issue 5 | Serracino-Inglott, Anthony |
| 2016 | Journal of Euromed pharmacy : issue 6 | Serracino-Inglott, Anthony |
| 1996-01 | Journal of Euromed Pharmacy : volume 1 : issue 3 | Serracino-Inglott, Anthony |
| 2024 | Knowledge and perceptions about Cannabidiol use | Calleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-03 | LC-HRMS analysis of a green steroid orthoesterification reaction | Sammut Bartolo, Nicolette; Zoidis, Grigoris; Gikas, Evangelos; Ferrito, Victor; Serracino-Inglott, Anthony |
| 2013-08 | Lifestyle modifications in metabolic syndrome | Cutajar, Leanne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011 | Management and patient knowledge of osteoporosis | Fenech, Judith; Galea, Raymond P.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-06 | Management of chemotherapy side effects in breast cancer patients | Caruana, Danika; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011 | Management of consumers' pharmaceutical waste in a pharmacy setting : part 2 | Attard, Karen; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011 | Management of consumers' pharmaceutical waste in a pharmacy setting : part I | Attard, Karen; Zarb Adami, Maurice; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2010 | Management of rheumatoid arthritis | Griscti, Suzanne; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Azzopardi, Lilian M.; Mallia, Carmel; Grech, Louise; Camilleri Vassallo, Franco; Cassar, Paul John; Coleiro, Bernard; Cassar, Karen; Aquilina, Doris; Anastasi, Alison |
| 2013-05 | Measuring student interest and perception of pharmacogenetics | Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2016-10 | Medication assessment tool for heart failure : standardisation to service optimisation | Anastasi, Alison; Grech, Louise; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | Medicinal cannabis use in rare diseases | Parovincaka, Jekaterina; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2020 | Meeting educational needs of pharmaceutical stakeholders : veterinary medicine | Borra, Jimenorose; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011 | Methicillin resistant S. Aureus in autopsy cases | Zammit, Marie Clare; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Cuschieri, Paul; Camilleri-Podesta, Marie Therese |
| 2014-03 | Method development for the quantification of ciprofloxacin in human plasma | Vella, Janis; Busuttil, Francesca; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Sammut Bartolo, Nicolette; LaFerla, Godfrey |
| 2014-03 | Method development for the quantification of clindamycin in human plasma | Vella, Janis; Mifsud, Martina; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Sammut Bartolo, Nicolette; LaFerla, Godfrey |
| 2012-03 | A mini-scale oral solid dosage production facility | Zerafa, R.; Serracino-Inglott, Anthony; Wismayer, Lilian; Azzopardi, Lilian M. |
| 2019-05 | Moving towards regulatory sciences through educational initiatives | Attard, Annalise; Muscat, Caroline; Mifsud Buhagiar, Luana; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | A multi-technique analytical approach for impurity profiling during synthesis : the case of difluprednate | Sammut Bartolo, Nicolette; Zoidis, Grigoris; Gikas, Evangelos; Benaki, Dimitra; Ferrito, Victor; Serracino-Inglott, Anthony |
| 2015 | Multimodal management as requirement for the clinical use of anticachexia drugs - a regulatory and a clinical perspective | Borg, John-Joseph; Anker, Stefan D.; Rosano, Giuseppe; Serracino-Inglott, Anthony; Strasser, Florian |
| 2020 | Navigating the science, the myths and the realities of COVID-19 pandemic | Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-10 | Neutropenia in patients receiving chemotherapy | Blundell, Bernardette; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014 | A new approach to improve the yield in the production of slow release oral dosage forms | Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2020 | Novel Coronavirus (2019-nCoV) seminar for healthcare professionals | Serracino-Inglott, Anthony; Gauci, Charmaine; Muscat, Caroline; Falzon, Sephorah; Camilleri, Charlene; Vella, Kristina; Attard, Annalise; Mifsud Buhagiar, Luana |
| 2019-09 | Nurses perception of intravenous medication administration errors in paediatrics | Al-Haddad, Dania; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2015-06 | Once daily gentamicin dosing in the intensive therapy unit | Thake, Annalisa; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019 | An online approach to enhance awareness on pharmacogenetics among pharmacists and physicians | Xuereb, Althea Marie; Mifsud Buhagiar, Luana; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2019-05 | Opinions of decision-makers on the clinical development and assessment of antineoplastic agents | Said, Dylan; Borg, John-Joseph; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2012 | Optimisation of abiraterone based non-steroidal lead molecules | Grima, A.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012 | Optimisation of Tyrosine-based lead molecules capable of Modulation of the Peroxisome Proliferator-Activated Receptor Gamma | Ciantar, J.; Shoemake, Claire; Mangani, C.; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019 | Optimising bench science to withstand regulatory scrutiny | Borg, John-Joseph; Melchiorri, Daniela; Sepodes, Bruno; Caramella, Carla M.; Tomino, Carlo; Micallef, Benjamin; Serracino-Inglott, Anthony |
| 2017-03 | Optimising drug therapy in older persons : design and implementation of a medication assessment tool for secondary prevention of stroke | Gauci, Marise; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019 | Orphan drug policies in different countries | Abbas, Amar; Vella Szijj, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2022 | Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia | Micallef, Benjamin; Nistico, Robert; Bjerrum, Ole Weis; Sarac, Sinan Bardakci; Butler, Dianne; Serracino-Inglott, Anthony; Borg, John Joseph |
| 2019-09 | Outcomes studied in leukaemia clinical trials : a need for harmonisation? | Said, Dylan; Borg, John-Joseph; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2009 | Palliative care in cancer patients | Attard Pizzuto, Maresca; Wirth, Francesca; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2011 | Palliative care in cancer patients : evaluating pharmacist intervention in a hospice setting | Sacco, Ryan; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-06 | Patient benefit of a medicines use review service | Camilleri, Matthew; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011 | Patient knowledge of colorectal cancer therapy side effects | Pirotta, Ilona; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Anastasi, Alison |
| 2016-10 | Patient safety in the use of NSAIDs | Farrugia, Jessica; Vella, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-10 | Patient-centred regulatory audits in community pharmacy | Attard, Annalise; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2022 | Patient-centred training for pharmaceutical good distribution practice in Pharmacy of Your Choice (POYC) | Bacayo, May F. D.; Grech, Louise; Serracino-Inglott, Anthony |
| 2015-10 | Patient-controlled analgesia in post-caesarean section | Mangion, Deborah; Vella, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | Perception of delivery systems used for medicinal cannabis | Bereketoglu, Ceren; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2019-03 | Perception of hospital pharmacists towards pharmacogenetic testing | Xuereb, Althea Marie; Wirth, Francesca; Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony |
| 2023 | Perception of Maltese healthcare professionals on cannabis for medicinal use | Zammit Dimech, David; Grech, Louise; Serracino-Inglott, Anthony |
| 2015-06 | Perception of medical practitioners on antibiotic prescribing by pharmacists | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-10 | Perception of oral anti-cancer treatment | Camilleri, Stephen; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-10 | Perception of pharmacists and patients of the pharmacist-of-your-choice scheme in community pharmacies | Xuereb, Marjean; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-10 | Perception of pharmacists and patients on point-of-care testing for PSA | Mizzi, Janica; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2021 | Perception of rare diseases and orphan medicines | Vassallo, Sharon; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2021 | Perception of risk among pharmaceutical stakeholders | Grech, Steve; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014 | Perception of use of liquid capsules | Brincat Ruffini, Lara; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013 | Perceptions of a newsletter for community pharmacists | Mercieca, Caroline; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2016-03 | Perceptions of potential antibiotic prescribing by pharmacists | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-10 | Perceptions on antibiotic prescribing by medical practitioners and pharmacists | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2021 | Perspectives of practices related to the implementation of the FMD | Almojero, Danielle Claire E.; Vella Szijj, Janis; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | Pet owner perception of the role of the pharmacist in animal care | Butler, Dianne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2009 | Pharmaceutical care aspects in systemic lupus erythematosus | Conti, Lucia; Wirth, Francesca; Grech, Louise; Mallia, Carmel; Camilleri Vassallo, Franco; Coleiro, Bernard; Cassar, Paul John; Cassar, Karen; Azzopardi, Lilian M.; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2011-10 | Pharmaceutical care in the management of paediatric rheumatology patients | Grech, Louise; Aquilina, Doris; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Ferrito, Victor; Borg, Andrew A. |
| 2016 | Pharmaceutical care models, tools for treating patients with rheumatoid arthritis | Grech, Louise; Ferrito, Victor; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018 | Pharmaceutical issues during the review of European Marketing Authorisation Applications in Malta | Chetcuti, Michael; Serracino-Inglott, Anthony; Flores, Gavril; Borg, John-Joseph |
| 2012-10 | The pharmaceutical services in lifestyle modifications : overweight and obesity management | Petroni, Vanessa; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2021 | Pharmaceuticals and the environment | Sammut Bartolo, Nicolette; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2022 | Pharmacist and physician perception of pharmacogenetic testing | Bruno Xuereb, Althea Marie; Wirth, Francesca; Mifsud Buhagiar, Luana; Camilleri, Liberato; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-09 | Pharmacist intervention in a heart failure clinic | Aquilina, Marie Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015 | Pharmacist intervention in a psychiatric setting | Bugeja, Ann; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-10 | Pharmacist intervention in a psychiatric setting | Bugeja, Ann; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2016-10 | Pharmacist intervention in multidisciplinary tasking of cancer patients | Camilleri, Ann; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013-10 | Pharmacist intervention in pain management following heart surgery | Agius Decelis, Danika; Zarb Adami, Maurice; Galea, Joseph; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-10 | Pharmacist intervention in patient monitoring in a psychiatric hospital | Mamo, Maria; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014 | Pharmacist interventions in non-prescription medicine use | Galea, Sephora; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-09 | Pharmacist perspective of prescribing errors | Kupka, Jeffrey; Zarb Adami, Maurice; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2015-09 | Pharmacist prescribing framework for ophthalmic and skin conditions | Casha, Gianella; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2017-10 | Pharmacist-led medicine use review for patients on anticoagulation therapy | Mifsud, Elena Marie; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Pharmacist-led medicine use review for patients on warfarin | Mifsud, Elena Marie; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019 | Pharmacist-led medicine use review in community pharmacy for patients on warfarin | Mifsud, Elena Marie; Wirth, Francesca; Camilleri, Liberato; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2011-10 | Pharmacist-led point-of-care testing in hypercholesterolaemia | Cutajar, Stephanie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019-05 | Pharmacists competence to resolve the therapeutic challenge of the valsartan saga | Muscat, Caroline; Attard, Annalise; Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony |
| 2018-11 | Pharmacogenetic testing for drugs used in malignancy | Xuereb, Althea Marie; Wirth, Francesca; Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony |
| 2019-03 | Pharmacogenetic testing for personalisation of statin therapy | Cerdá Iñesta, Judith; Wirth, Francesca; Mifsud Buhagiar, Luana; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony |
| 2018-05 | Pharmacogenetics as a tool for teaching precision medicine to pharmacy students | Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2019-09 | Pharmacogenomics information in official drug labelling | Azzopardi, Yasmine; Wirth, Francesca; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019-09 | Pharmacovigilance analysis of statin-associated muscle symptoms | Cerdá Iñesta, Judith; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2022 | Pharmacy driven assessment of training needs in quality systems for laboratory personnel | Rivera, Rogelio; Grech, Louise; Serracino-Inglott, Anthony |
| 2008-08 | Pharmacy services in emergency management | Anastasi, Alison; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Zarb Adami, Maurice |
| 2018-03 | Physicochemical properties of herbal tea | Rapa, Nicholas; Vella, Janis; Serracino-Inglott, Anthony; Attard, Everaldo |
| 2019-09 | Physicochemical properties of products obtained from the local carob tree varieties | Galea, Luca; Attard, Everaldo; Serracino-Inglott, Anthony |
| 2015 | The phytochemical constitution of Maltese medicinal plants : propagation, isolation and pharmacological testing | Attard, Everaldo; Attard, Henrietta; Tanti, Antoine; Azzopardi, Jurgen; Sciberras, Mario; Pace, Victor; Buttigieg, Neville; Mangion Randon, Andrew; Rossi, Bernardette; Parnis, Marie Josette; Vella, Karin; Zammit, Michelle; Serracino-Inglott, Anthony |
| 2016-10 | A pilot study for methadone dispensing from a community pharmacy | Caruana, Mark; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-10 | A plan for improving pharmaceutical care for psychiatric patients | Bugeja, Claire; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-10 | Point-of-care testing for streptococcus pyogenes in community pharmacies | Scicluna, Laura; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015 | Point-of-care testing for urine analysis of microalbuminuria for diabetic patient management | Ungaro, Shaun; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-10 | Point-of-care testing for urine analysis of microalbuminuria for diabetic patient management | Ungaro, Shaun; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-03 | Polyvinyl alcohol as a raw material in fused-deposition modelling 3D printing of solid oral dosage forms | Borg, Kurt A.; Vella, Janis; Ferrito, Victor; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2023-05 | Post-graduate course in pharmaceutical and regulatory sciences | Serracino-Inglott, Anthony; Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Vella Szijj, Janis; Azzopardi, Lilian M. |
| 2017-09 | Postgraduate professional doctorate in pharmacy programme | Attard Pizzuto, Maresca; Grech, Louise; Sammut Bartolo, Nicolette; Vella, Janis; Wirth, Francesca; Pham, Jennifer T.; Haaf-Mactal, Christina; Lau, Alan H.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-03 | Practical implications in shelf-life extension of anticancer admixtures | Said, Dylan; Galea, Sylvania; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-01 | Practical implications of pharmacogenetics in antidepressant treatment : the case of amitriptyline | Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony; LaFerla, Godfrey; Grech, Anton |
| 2019 | Practical liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of amitriptyline, nortriptyline and their hydroxy metabolites in human serum | Mifsud Buhagiar, Luana; Sammut, Carmel; Chircop, Yana; Axisa, Kersty; Sammut Bartolo, Nicolette; Vella Szijj, Janis; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2016-09 | Practices and perceptions of medical practitioners on potential antibiotic prescribing by pharmacists | Attard Pizzuto, Maresca; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2009-11 | Predictors for post-caesarean section pain and analgesic requirement | Buhagiar, Luana; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Cassar, Olivia Anne; Brincat, Mark P.; Buttigieg, George Gregory |
| 2011 | Predictors of post-caesarean section pain and analgesic consumption | Buhagiar, Luana; Cassar, Olivia A.; Brincat, Mark P.; Buttigieg, George Gregory; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Azzopardi, Lilian M. |
| 2018 | Preparing for pharmacist prescribing in Maltese hospitals | Aquilina, Abigail; Wirth, Francesca; Attard Pizzuto, Maresca; Grech, Louise; Camilleri, Liberato; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 1992 | Prevalence and drug treatment of the parkinsonian syndrome in Malta | Serracino-Inglott, Anthony; Farrugia, Simone; Ferrito, Mary Nancy |
| 2015-10 | Prevalence of peripheral arterial disease and diabetes | Vella, Janis; Cassar, Kevin; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2009-11 | Prevalence, characteristics and management of endometriosis | Camilleri, Lorraine; Schembri, Alexia; Buttigieg, George Gregory; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013 | Pre‑operative pain sensitivity : a prediction of post‑operative outcome in the obstetric population | Mifsud Buhagiar, Luana; Cassar, Olivia Anne; Brincat, Mark P.; Buttigieg, George Gregory; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Azzopardi, Lilian M. |
| 2017-09 | Professional practice academic component in a postgraduate doctorate in pharmacy programme | Attard Pizzuto, Maresca; Gauci, Marise; Grech, Louise; Sammut Bartolo, Nicolette; Vella, Janis; Wirth, Francesca; Pham, Jennifer T.; Haaf-Mactal, Christina; Lau, Alan H.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-10 | Proposing a framework for INR testing and anticoagulation management in community pharmacies | Mifsud, Elena Marie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-10 | Proposing a framework of pharmacist prescribing within a multidisciplinary team context | Vella, Elena Maria; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2013-08 | Proposing a point-of-care testing service for H.pylori in community pharmacies | Attard, Daniel; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2016 | Proposing guidelines for responsible person eligibility in Malta | Corrieri, Simon; Serracino-Inglott, Anthony |
| 2017-09 | Public perception of antibiotic prescribing by pharmacists | Attard Pizzuto, Maresca; Sivridas, Merve; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Bouvy, Marcel L. |
| 2020 | Public perception of generic medicines in Malta | Sammut Bartolo, Nicolette; Ignas, Louella Bianca; Wirth, Francesca; Attard Pizzuto, Maresca; Vella Szijj, Janis; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2022 | QT shortening : a proarrhythmic safety surrogate measure or an inappropriate indicator of it? | Tanti, Amy; Micallef, Benjamin; Vella Szijj, Janis; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2014-03 | A qualitative and quantitative method for difluprednate using high performance liquid chromatography | Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Ferrito, Victor; Azzopardi, Lilian M. |
| 2012-03 | Quality improvements in good distribution practice | Buttigieg, Suzanne; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018 | Quality issues identified during the evaluation of biosimilars by the european medicines agency’s committee for medicinal products for human use | Cilia, Mark; Ruiz, Sol; Richardson, Peter; Salmonson, Tomas; Serracino-Inglott, Anthony; Wirth, Francesca; Borg, John-Joseph |
| 2013-08 | Quality management system for non-clinical pharmacy services at a rehabilitation hospital | Agius, John; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-09 | Quality of life in hypertensive dialysis patients | Mercieca, Anne Marie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014 | Quality risk management implementation for a medicinal products wholesale dealer | Busuttil, Adrian; Serracino-Inglott, Anthony |
| 2018-11 | Rare diseases and orphan drug availability in Malta | Abbas, Amar; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2021 | Rare diseases and orphan medicines | Vassallo, Sharon; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2022 | Rare diseases and orphan medicines : knowledge and perceptions of healthcare professionals and the public | Vassallo, Sharon; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2018-09 | Reaching concordance in community pharmacy regulatory audits | Attard, Annalise; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2022 | Reflections on the use of cannabidiol for medicinal purposes and the views of healthcare professionals | Calleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2020 | Regulation of medical devices in Europe and Africa | Dusabe, Gloria; Serracino-Inglott, Anthony |
| 2021 | Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU | Butler, Dianne; Vucic, Katarina; Straus, Sabine; Cupelli, Amelia; Micallef, Benjamin; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2019 | Regulatory sciences and translational pharmacogenetics : amitriptyline as a case in point | Mifsud Buhagiar, Luana; Micallef, Benjamin; Borg, John-Joseph; Vella, Helen; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2012-10 | Responding to urinary tract infections during pregnancy in community pharmacy | Busuttil, Katya; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2016-10 | Retrospective analysis of serum digoxin concentrations at Mater Dei Hospital | Vella, John; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2021 | Review of methods for TPMT biomarker genotyping in the personalisation of thiopurine therapy | Camilleri, Leanne; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018 | A review of the national adverse drug reaction (ADR) & medication errors reporting system of Malta | Borg, John-Joseph; Serracino-Inglott, Anthony; Al-Haddad, Dania |
| 2021 | Risk assessment in pharmaceutical processes | Bezzina, Abigail; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-01 | Risk assessment models for the development of complications in Maltese type 2 diabetic patients | Baldacchino, Sarah; Camilleri, Liberato; Fava, Stephen; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-11 | Risk assessment of prescribing errors on medical prescriptions in Malta and Germany | Kupka, Jeffrey; Attard Pizzuto, Maresca; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2018-10 | Risk assessment of prescribing errors on medical prescriptions in Malta and Germany | Kupka, Jeffrey; Zarb Adami, Maurice; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony |
| 2015-09 | Risk assessment of the preparation of intravenous admixtures within an acute hospital setting | Saliba, Diane; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023 | Risk-based approach to inappropriate prescribing | Salomone, Philippa Galea; Serracino-Inglott, Anthony; Attard Pizzuto, Maresca |
| 2015-09 | A risk-based approach towards pharmacist prescribing | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023-09 | Risks in medical device vigilance | Almojero, Danielle Claire E.; Serracino-Inglott, Anthony; Attard Pizzuto, Maresca |
| 2017-03 | Risks in medication reconciliation during hospital admission | Formosa, Tresha; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2014-05 | Risks in pharmacist prescribing | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2014-03 | Risks in pharmacist prescribing guidelines | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023-05 | Risks in pharmacy practice research | Amar, Jaycerie Joy; Serracino-Inglott, Anthony; Attard Pizzuto, Maresca |
| 2014-10 | Risks involved in diminished patient access to medication | Degiorgio, Attilio Antonio; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-03 | Risks of drug induced effects and hospital admissions | Farrugia, Nicola; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2021 | The role and value of a ward based pharmacist in the intensive care unit : the critical care physicians' and nurses' perceptions | Rayner, Deborah L.; Grech, Louise; Serracino-Inglott, Anthony |
| 2017 | The role of pharmacogenetics in rediscovering old drugs : spotlight on amitriptyline | Mifsud Buhagiar, Luana; Grech, Anton; Casha, Marilyn; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2016-10 | Safer anticoagulation management in the community : a pharmacist-led approach | Mifsud, Elena Marie; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 1988-04 | A safer organism for the Rideal-Walker test | Serracino-Inglott, Anthony |
| 2019 | Safety implications of low-dose amitriptyline in neuropathic pain | Mifsud Buhagiar, Luana; Casha, Marilyn; Grech, Anton; Micallef, Benjamin; Borg, John-Joseph; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2014-09 | Sample preparation for the analysis of clindamycin in tissue | Vella, Janis; Vodka, Margaret; Sammut Bartolo, Nicolette; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2022 | Seminar on biosimilar medicine | Falzon, Sephorah; Mamo, Maria; Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony |
| 2018 | Serum digoxin concentrations : a retrospective analysis | Vella, John; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2017-09 | Serum digoxin concentrations : clinical signals | Vella, John; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013-08 | Setting up a helpline for pharmacy services | Corrieri, Simon; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | The shift from class-based to online learning during COVID-19 : a student and academic perception | Sammut Bartolo, Nicolette; Attard Pizzuto, Maresca; Wirth, Francesca; Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2011-10 | Side effects of methotrexate treatment in rheumatoid arthritis patients | Cuschieri, K.; Grech, Louise; Coleiro, Bernard; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2023 | Signals for quality assurance in medicinal products regulatory sciences | Sammut, Valentina; Serracino-Inglott, Anthony |
| 2015-09 | A simple HPLC-UV method for the analysis of ciprofloxacin in tissue | Vella, Janis; Vella, Maria; Sammut Bartolo, Nicolette; Sammut, Carmel; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2014 | A simple HPLC-UV method for the determination of clindamycin in human plasma | Mifsud, Martina; Vella Szijj, Janis; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Sammut Bartolo, Nicolette; LaFerla, Godfrey; Sammut, Carmel |
| 2015 | A simple HPLC–UV method for the determination of ciprofloxacin in human plasma | Vella Szijj, Janis; Busuttil, Francesca; Sammut Bartolo, Nicolette; Sammut, Carmel; Ferrito, Victor; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2019-09 | A simple method for the determination of water content in tetrahydrofuran | Xiberras, Maria; Attard, Everaldo; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2018-03 | Simplification of procedures required for registration of medicines | Cilia, Francesca; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-11 | A simplified approach for the registration of medicines in small European countries | Cilia, Francesca; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-09 | SLCO1B1 genetic polymorphisms in cardiac patients on simvastatin | Cerdá Iñesta, Judith; Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony |
| 1989 | Smoking behaviour in pregnant Maltese females | Bonnici, Dorianne; Cacciottolo, Joseph M.; Serracino-Inglott, Anthony |
| 2021 | Software validation in the pharmaceutical industry | Sammut, Chris; Vella Szijj, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 1971-07 | Some physical and chemical incompatibilities of drugs for I.V. administration | Kramer, Warren; Serracino-Inglott, Anthony; Cluxton, Robert |
| 2012 | Standard operating procedures for quality control in the pharmaceutical industry | Mansor, Enas; Serracino-Inglott, Anthony |
| 2012 | Standard operating procedures in pharmaceutical quality systems | Serge, Simon; Serracino-Inglott, Anthony |
| 2020 | Standardised interpretation of CYP2D6 genotypes and phenotypes : from lab reports to clinical recommendations | Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; LaFerla, Godfrey |
| 2014 | Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta | Mamo, Maria; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-03 | Storage of medicines | Coleiro, Daphne; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2013 | Storing medicines while reducing electricity consumption | Coleiro, Daphne; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Strategic analysis for sustainable pharmaceutical procurement | Muscat, Caroline; Anastasi, Alison; Wirth, Francesca; Farrugia, Karl; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2018-11 | Structure activity relationship of drugs of abuse | Axisa, Kersty; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2016-05 | Student evaluation of coursework for pharmaceutical technology modules | Sammut Bartolo, Nicolette; Attard Pizzuto, Maresca; Vella, Janis; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Student perception of the pharmacy practice resource unit | Cassar, Francesco; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2019-05 | Students’ perception of risk in pharmaceutical processes | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2015-05 | Students’ perception of risk in pharmacy | Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | Systematic reviews about medicinal cannabis dosage forms | Bereketoglu, Ceren; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony |
| 2016-04 | Temperature control and risk management in pharmaceutical processes | Chircop, Matthew; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-09 | Therapeutic and economic implications of regulating stem cell therapy and blood components | Attard, Alison; Wirth, Francesca; Serracino-Inglott, Anthony |
| 2022 | Therapeutic potential of cannabidiol | Calleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony |
| 2021 | A three-year post-graduate Doctorate in Pharmacy course incorporating professional, experiential and research activities : a collaborative innovative approach | Vella Szijj, Janis; Attard Pizzuto, Maresca; Sammut Bartolo, Nicolette; Wirth, Francesca; Grech, Louise; Pham, Jennifer T.; Haaf-Mactal, Christina; Lau, Alan H.; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2009 | Time and motion study for pharmacists’ activities in a geriatric hospital | Wirth, Francesca; Azzopardi, Lilian M.; Gauci, Marise; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2008 | Time motion study for pharmacists’ activities in a geriatric hospital | Wirth, Francesca; Azzopardi, Lilian M.; Gauci, Marise; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2009-06 | Tolerance to an 8mg dose of perindopril for secondary prevention of coronary artery disease | Manduca, Emma; Azzopardi, Lilian M.; Manche, Alexander; Zarb Adami, Maurice; Serracino-Inglott, Anthony |
| 2015-10 | Towards a philosophy of risk | Attard Pizzuto, Maresca; Mangion, Claude; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | Treatment of Leber’s hereditary optic neuropathy : an overview of recent developments | Zuccarelli, Marta; Vella Szijj, Janis; Serracino-Inglott, Anthony; Borg, John-Joseph |
| 2020 | Understanding educational needs of pharmaceutical stakeholders : pharmacy operators | Amar, Jaycerie Joy; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2020 | Understanding pharmacogenetics and drug interactions through case-based examples | Mifsud Buhagiar, Luana; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2021 | Understanding risks in pharmaceutical processes | Zahra, Melanie; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2017-03 | Update and evaluation of the Maltese medicines handbook | Scicluna, Timothy; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; Vella, Janis |
| 2012-10 | Use of compliance aid devices | Cachia, Deborah; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2016-10 | Use of compliance aid devices in psychiatric patients | Borg Falzon, Estelle; Wirth, Francesca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-10 | Use of diuretics in elderly patients with congestive heart failure | Atkins, Sean Ryan; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2012-10 | Use of paediatric protocols as training tools for pharmacy students | Muscat, Martina; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
| 2015-09 | Use of proton pump inhibitors and effects of amylase and other enzymes | Cassar, Ritianne; Azzopardi, Lilian M.; Serracino-Inglott, Anthony; LaFerla, Godfrey |
| 2016-04 | The use of rheumatoid arthritis medication assessment tool within pharmaceutical care plans | Grech, Louise; Ferrito, Victor; Camilleri, Liberato; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2020 | UV/Vis spectroscopy in determining water content in solvents | Xiberras, Maria; Sammut Bartolo, Nicolette; Attard, Everaldo; Ferrito, Victor; Serracino-Inglott, Anthony |
| 2001 | Validating tools for the monitoring of community pharmacy services | Azzopardi, Lilian M.; Salek, Sam; Serracino-Inglott, Anthony; Zarb Adami, Maurice; Buhagiar, Anton |
| 2000 | Validation instruments for health promotion in the community pharmacy setting | Azzopardi, Lilian M.; Salek, Sam; Serracino-Inglott, Anthony; Zarb Adami, Maurice |
| 2018-09 | Validation of a method to test for pesticides residues | Falzon, Pauline; Zammit, Ramon; Spiteri, David; Grech Bonnici, Paula; Serracino-Inglott, Anthony |
| 1988 | Validation of community pharmacy : confirming the effectiveness of a pharmacist in a community setting | Azzopardi, Lilian M.; Salek, Sam; Serracino-Inglott, Anthony; Zarb Adami, Maurice |
| 2019-03 | The valsartan saga : pharmacists competence to resolve the therapeutic challenge | Muscat, Caroline; Attard, Annalise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2019-09 | The valsartan saga : science, myths and realities | Baldacchino, Stephania; Muscat, Caroline; Attard, Annalise; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
| 2012-10 | Veterinary medicines : knowledge and perception of Maltese pharmacists and pharmacy students | Soler, Bernard; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
